AAAAAA

   
Results: 1-17 |
Results: 17
BIOLOGIC ACTIVITY OF INTERLEUKIN-1 (IL-1)ALPHA IN PATIENTS WITH REFRACTORY MALIGNANCIES
Authors: ROSENTHAL MA DENNIS D LIEBES L FURMANSKI P CARON D GARRISON L WIPROVNICK J PEACE D ORATZ R SPEYER J CHACHOUA A
Citation: Ma. Rosenthal et al., BIOLOGIC ACTIVITY OF INTERLEUKIN-1 (IL-1)ALPHA IN PATIENTS WITH REFRACTORY MALIGNANCIES, Journal of immunotherapy, 21(5), 1998, pp. 371-378
IL-2 PLUS G-CSF AS A MOBILIZATION REGIMEN IN ADVANCED BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY - MARKED EXPANSION OF ACTIVATED T AND NK CELLS WITH ENHANCED CYTOLYTIC ACTIVITY WITHIN THE AUTOGRAFT, WITHOUT COMPROMISE OF ME HEMATOLOGIC ENGRAFTMENT
Authors: SOSMAN J MOSS ST SOROKIN P MARTONE B DEVINE S PEACE D STOCK W HOFFMAN R STIFF P THOMASON D WICKREMA A AMIN K VANBESIEN K
Citation: J. Sosman et al., IL-2 PLUS G-CSF AS A MOBILIZATION REGIMEN IN ADVANCED BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY - MARKED EXPANSION OF ACTIVATED T AND NK CELLS WITH ENHANCED CYTOLYTIC ACTIVITY WITHIN THE AUTOGRAFT, WITHOUT COMPROMISE OF ME HEMATOLOGIC ENGRAFTMENT, Experimental hematology, 26(8), 1998, pp. 321-321
REVERSAL OF DELAYED HYPERACUTE RENAL-ALLOGRAFT REJECTION WITH A TACROLIMUS-BASED THERAPEUTIC REGIMEN
Authors: LOSS GE GREWAL HP SIEGEL CT PEACE D MEAD J BRUCE DS CRONIN DC MILLIS JM NEWELL KA WOODLE ES
Citation: Ge. Loss et al., REVERSAL OF DELAYED HYPERACUTE RENAL-ALLOGRAFT REJECTION WITH A TACROLIMUS-BASED THERAPEUTIC REGIMEN, Transplantation proceedings, 30(4), 1998, pp. 1249-1250
FETAL HEMOGLOBIN IN SICKLE-CELL-ANEMIA - DETERMINANTS OF RESPONSE TO HYDROXYUREA
Authors: STEINBERG MH LU ZH BARTON FB TERRIN ML CHARACHE S DOVER GJ JONES ES STRAYHORN D ROSSE W PHILLIPS G PEACE D JOHNSONTELFAIR A MILNER P KUTLAR A TRACY A BALLAS SK ALLEN GE MOSHANG J SCOTT B ANDERSON A SABAHI V PEGELOW C TEMPLE D CASE E HARRELL R CHILDERIE S EMBURY S SCHMIDT B DAVIES D KOSHY M TALISCHYZAHED N DORN L PENDARVIS G MCGEE M TELFER M DAVIS A CASTRO H FINKE E PERLIN E SITEMAN J GASCON P DIPAOLO P GARGIULO S ECKMAN J BAILEY JH PLATT A WALLER PL RAMIREZ G KNORS V HERNANDEZ S RODRIGUEZ EM WILKES E VICHINSKY E CLASTER S EARLES A KLEMAN K MCLAUGHLIN K SWERDLOW P SMITH W MADDOX B USRY L BRENNER A WILLIAMS K OBRIEN R GENTHER K SHURIN S BERMAN B CHIARUCCI K KEVERLINE L OLIVIERI N SHAW D LEWIS N BRIDGES K TYNAN B WINOGRAD C BELLEVUE R DOSIK H SHEIKHAI M RYANS P SOUFFRANT H PRCHAL J BRADDOCK J MCARDLE T CARLOS T SCHMOTZER A GARDNER D MOORE R DOVER G BERGNER M EWART C ECKERT S LENT C ULLRICH J FISHPAW L TIRADO G IBSON J MOELLER T NAGEL T TERRIN M MCMAHON P HANDY C HARRIS D CANNER M DEPKIN J MEINERT N CARROLL M GIRO R KARABELAS S KELLY C HEYMAN M BEILINSON P DRUSKIN M ELLIS P FLOOD WA KRAVITZ S LANZKRON S LORICA V MOLITERNO A NAHUM A NESBITT JA ROSENTHAL L SHARFMAN W STREIFF M WACHSMAN M BRAY P VANDANG C CASELLA J MCGUIRE M PATRICK L SCHAAD H STEINER C JOHNSON C BANK A CUTTER G DAVIS E HUNTLEY O LESSIN L PLATT O SECUNDY MG BONDS D REID C GELLER N WACLAWIW M
Citation: Mh. Steinberg et al., FETAL HEMOGLOBIN IN SICKLE-CELL-ANEMIA - DETERMINANTS OF RESPONSE TO HYDROXYUREA, Blood, 89(3), 1997, pp. 1078-1088
HYDROXYUREA AND SICKLE-CELL-ANEMIA - CLINICAL UTILITY OF A MYELOSUPPRESSIVE SWITCHING AGENT
Authors: CHARACHE S BARTON FB MOORE RD TERRIN ML STEINBERG MH DOVER GJ BALLAS SK MCMAHON RP CASTRO O ORRINGER EP JONES S STRAYHORN D ROSSE W PHILLIPS G PEACE D JOHNSONTELFAIR A MILNER P KUTLAR A TRACY A ALLEN GE MOSHANG J STEINBERG M ANDERSON A SABAHI V PEGELOW C TEMPLE D CASE E HARRELL R EMBURY S SCHMIDT B KOSHY M TALISCHYZAHED N DORN L PENDARVIS G MCGEE M TELFER M DAVIS A FINKE H PERLIN E SITEMAN J GASCON P DIPAOLO P GARGIULO S ECKMAN J BAILEY JH PLATT A WALLER L RAMIREZ G KNORS V HERNANDEZ S RODRIGUEZ E WILKES E VICHINSKY E CLASTER S EARLES A KLEMAN K MCLAUGHLIN K SWERDLOW P SMITH W MADDOX B USRY L BRENNER A WILLIAMS K SHURIN S BERMAN B CHIARUCCI K KEVERLINE L OLIVIERI N SHAW D LEWIS N BRIDGES K WINOGRAD C BELLEVUE R DOSIK H SHEIKAI M RYANS P SOUFFRANT H PRCHAL J BRADDOCK J MCARDLE T CARLOS T SCHMOTZER A GARDNER D NIMEH N MCCOY S CORLEY P
Citation: S. Charache et al., HYDROXYUREA AND SICKLE-CELL-ANEMIA - CLINICAL UTILITY OF A MYELOSUPPRESSIVE SWITCHING AGENT, Medicine, 75(6), 1996, pp. 300-326
SINUS SKELETONIZATION - A TREATMENT FOR DURAL ARTERIOVENOUS-MALFORMATIONS OF THE TENTORIAL APEX - REPORT OF 2 CASES
Authors: LUCAS CP DEOLIVEIRA E TEDESCHI H SIQUEIRA M LOURENZI M PISKE RL CONTI M PEACE D
Citation: Cp. Lucas et al., SINUS SKELETONIZATION - A TREATMENT FOR DURAL ARTERIOVENOUS-MALFORMATIONS OF THE TENTORIAL APEX - REPORT OF 2 CASES, Journal of neurosurgery, 84(3), 1996, pp. 514-517
IL-2 PLUS G-CSF FOR PERIPHERAL CELL MOBILIZATION IN BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY - PRELIMINARY-RESULTS REVEAL MARKED INCREASES IN ACTIVATED T-CELL AND NK-CELL IN THE MOBILIZED STEM-CELL SOURCE, WHITE SUBSEQUENT HEMATOLOGIC RECOVERY FOLLOWING
Authors: SOSMAN J MOSS ST MARTONE B BAYER R PEACE D STOCK W STIFF PJ
Citation: J. Sosman et al., IL-2 PLUS G-CSF FOR PERIPHERAL CELL MOBILIZATION IN BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY - PRELIMINARY-RESULTS REVEAL MARKED INCREASES IN ACTIVATED T-CELL AND NK-CELL IN THE MOBILIZED STEM-CELL SOURCE, WHITE SUBSEQUENT HEMATOLOGIC RECOVERY FOLLOWING, Blood, 88(10), 1996, pp. 2555-2555
A PHASE-II TRIAL OF HIGH-DOSE MITOXANTRONE, CARBOPLATIN, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW RESCUE FOR RECURRENT EPITHELIAL OVARIAN-CARCINOMA - ANALYSIS OF RISK-FACTORS FOR CLINICAL OUTCOME
Authors: STIFF P BAYER R CAMARDA M TAN S DOLAN J POTKUL R LOUTFI S KINCH L SOSMAN J PEACE D RAD N MCKENZIE RS
Citation: P. Stiff et al., A PHASE-II TRIAL OF HIGH-DOSE MITOXANTRONE, CARBOPLATIN, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW RESCUE FOR RECURRENT EPITHELIAL OVARIAN-CARCINOMA - ANALYSIS OF RISK-FACTORS FOR CLINICAL OUTCOME, Gynecologic oncology, 57(3), 1995, pp. 278-285
EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA
Authors: CHARACHE S TERRIN ML MOORE RD DOVER GJ BARTON FB ECKERT SV MCMAHON RP BONDS DR ORRINGER E JONES S STRAYHORN D ROSSE W PHILLIPS G PEACE D JOHNSONTELFAIR A MILNER P KUTLAR A TRACY A BALLAS SK ALLEN GE MOSHANG J SCOTT B STEINBERG M ANDERSON A SABAHI V PEGELOW C TEMPLE D CASE E HARRELL R CHILDERIE S EMBURY S SCHMIDT B DAVIES D KOSHY M TALISCHYZAHED N DORN L PENDARVIS G MCGEE M TELFER M DAVIS A CASTRO O FINKE H PERLIN E SITEMAN J GASCON P DIPAOLO P GARGIULO S ECKMAN J BAILEY JH PLATT A WALLER L RAMIREZ G KNORS V HERNANDEZ S RODRIGUEZ EM WILKES E VICHINSKY E CLASTER S EARLES A KLEMAN K MCLAUGHLIN K SWERDLOW P SMITH W MADDOX B USRY L BRENNER A WILLIAMS K OBRIEN R GENTHER K SHURIN S BERMAN B CHIARUCCI K KEVERLINE L OLIVIERI N SHAW D LEWIS N BRIDGES K TYNAN B WINOGRAD C BELLEVUE R DOSIK H SHEIKHAI M RYANS P SOUFFRANT H PRCHAL J BRADDOCK J MCARDLE T CARLOS T SCHMOTZER A GARDNER D MOORE R DOVER G BERGNER M EWART C ECKERT S LENT C ULRICH J FISHPAW L TIRADO G GIBSON J MOELLER T NAGEL T TERRIN M HANDY C HARRIS D CANNER M DEPKIN J MEINERT N CARROLL M GIRO R KARABELAS S KELLY C HEYMAN M BEILINSON P DRUSKIN M ELLIS P FLOOD WA KRAVITZ S LANZKRON S LORICA V MOLITERNO A NAHUM A NESBITT JA ROSENTHAL L SHARFMAN W STREIFF M WACHSMAN M BRAY P VANDANG C CASELLA J MCGUIRE M PATRICK L SCHAAD H STEINER C JOHNSON C BANK A CUTTER G DAVIS CE HUNTLEY O LESSIN L PLATT O GRAYSECUNDY M BONDS D REID C GELLER H WACLAWIW M
Citation: S. Charache et al., EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA, The New England journal of medicine, 332(20), 1995, pp. 1317-1322
PHASE IB TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COMBINED WITH MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATICMELANOMA
Authors: CHACHOUA A ORATZ R LIEBES L ALTER RS FELICE A PEACE D VILCEK J BLUM RH
Citation: A. Chachoua et al., PHASE IB TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COMBINED WITH MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATICMELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 16(2), 1994, pp. 132-141
MONOCYTE ACTIVATION FOLLOWING SYSTEMIC ADMINISTRATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: CHACHOUA A ORATZ R HOOGMOED R CARON D PEACE D LIEBES L BLUM RH VILCEK J
Citation: A. Chachoua et al., MONOCYTE ACTIVATION FOLLOWING SYSTEMIC ADMINISTRATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Journal of immunotherapy with emphasis on tumor immunology, 15(3), 1994, pp. 217-224
CIRCADIAN ORGANIZATION AND RESPONSE OF THE ERYTHRON
Authors: WOOD P PEACE D HRUSHESKY W
Citation: P. Wood et al., CIRCADIAN ORGANIZATION AND RESPONSE OF THE ERYTHRON, Journal of cellular biochemistry, 1994, pp. 26-26
EFFICACY OF CHRONIC ERYTHROPOIETIN IS DEPENDENT UPON THE TIME OF DAY OF ITS ADMINISTRATION
Authors: WOOD PA PEACE D TROHA T MANN G HRUSHESKY WJM
Citation: Pa. Wood et al., EFFICACY OF CHRONIC ERYTHROPOIETIN IS DEPENDENT UPON THE TIME OF DAY OF ITS ADMINISTRATION, Experimental hematology, 22(8), 1994, pp. 707-707
UNPURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED REFRACTORY INDOLENT NON-HODGKINS-LYMPHOMA CAN LEAD TO LONG-TERM PROGRESSION FREE SURVIVAL
Authors: LOUTFI S STIFF P BAYER R SOSMAN J PEACE D FISHER R
Citation: S. Loutfi et al., UNPURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED REFRACTORY INDOLENT NON-HODGKINS-LYMPHOMA CAN LEAD TO LONG-TERM PROGRESSION FREE SURVIVAL, Blood, 84(10), 1994, pp. 10000491-10000491
ENDOGENOUS ERYTHROPOIESIS AND ERYTHROPOIETIN RESPONSIVENESS ARE CIRCADIAN TIME-DEPENDENT
Authors: WOOD P PEACE D HRUSHESKY W
Citation: P. Wood et al., ENDOGENOUS ERYTHROPOIESIS AND ERYTHROPOIETIN RESPONSIVENESS ARE CIRCADIAN TIME-DEPENDENT, Blood, 82(10), 1993, pp. 10000225-10000225
PHASE-I TRIAL OF INTERLEUKIN-3 (IL-3) PRE-BONE MARROW HARVEST FOLLOWED BY GM-CSF WITH HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW RESCUE (ABMT) IN PATIENTS WITH SOLID TUMORS
Authors: SOSMAN J PELISKA J OLDENBURG D UNVERZAGT K BENDER J BAYER R PEACE D KINCH L RAD N STIFF P
Citation: J. Sosman et al., PHASE-I TRIAL OF INTERLEUKIN-3 (IL-3) PRE-BONE MARROW HARVEST FOLLOWED BY GM-CSF WITH HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW RESCUE (ABMT) IN PATIENTS WITH SOLID TUMORS, Blood, 82(10), 1993, pp. 10000430-10000430
RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR PATIENTS WITH DELAYED ERYTHROPOIESIS AFTER BONE-MARROW TRANSPLANTATION
Authors: PELISKA J MILLER C BISHOP M MILLS S SOSMAN J BAYER R PEACE D STIFF P
Citation: J. Peliska et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR PATIENTS WITH DELAYED ERYTHROPOIESIS AFTER BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000639-10000639
Risultati: 1-17 |